Regulators are considering whether to authorize the pill’s emergency use in adults who have been experiencing symptoms for less than five days and, if so, how to define who’s considered high risk.
Related posts:
Fauci calls 500,000 coronavirus deaths ‘terrible’
Supreme Court to review Trump curbs on abortion clinics, immigrant benefits
Biden administration sending masks to poor communities
FDA panel reviewing Johnson & Johnson vaccine says it has important advantages
Fauci: AstraZeneca needs to ‘straighten out’ vaccine data
Trump CDC chief: Coronavirus ‘escaped’ from Chinese lab
CDC director: Delta variant is growing threat to unvaccinated people
CDC set to recommend vaccinated Americans wear masks indoors again
‘The CDC hasn’t changed’: Biden’s top health officials try to sell new masking guidance
CDC vaccine panel endorses vaccine for kids 5-11
Pfizer asks FDA to authorize Covid shot for children under 5
Biden’s relaunched cancer moonshot needs funding for liftoff
